Higher spontaneous apoptotic index in small cell compared with non-small cell lung carcinoma cell lines; lack of correlation with Bcl-2/Bax

Lung Cancer

Volumn 22, Issue 1, 1998, Pages 1-13

  Sirzén, Florin ^a   Zhivotovsky, Boris ^b   Nilsson, Anders ^b   Bergh, Jonas ^c   Lewensohn, Rolf ^a,b,d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d Swedish Radiation Protection Authority   (Sweden)

Author keywords

Apoptosis; Bcl 2; Caspase 3; Lung carcinoma cell lines

Indexed keywords

CYSTEINE PROTEINASE; DNA FRAGMENT; MYC PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CHROMATIN; CONTROLLED STUDY; DNA DETERMINATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MOLECULAR WEIGHT; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

EID: 0032191676     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(98)00066-X     Document Type: Article

References (42)

1. Ben-Ezra J.M., Kornstein M.J., Grimes M.M., Krystal G. Small cell carcinomas of the lung express Bcl-2 protein. Am J Pathol. 145:1994;1036-1040.
2. Bergh J., Larsson E., Zech L., Nilsson K. Establishment and characterization of two neoplastic cell lines (U-1285 and U-1568) derived from small cell carcinoma of the lung. Acta Pathol Microbiol Immunol Scand (Sec. A). 90:1982;149-158.
3. Bergh J., Nilsson K., Ekman R., Giovanella B. Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung. Acta Pathol Microbiol Immunol Scand (Sec. A). 93:1985;133-147.
4. Brambilla E., Negoescu A., Gazzeri S., Lantuéjoul S., Moro D., Brambilla C., Coll J.L. Apoptosis-related factors p53, Bcl2 and Bax in neuroendocrine lung tumours. Am J Pathol. 149:1996;1941-1952.
5. Brambilla E., Negoescu A., Moro D., Lantuéjoul S., Brambilla C., Hasleton P. Relation of Bax and Bcl-2 with apoptosis and grade in neuroendocrine (NE) tumours other than small cell lung carcinoma. Lung Cancer (abstract 667). 18(1):1997;171.
6. Brown D.G., Sun X., Cohen G.M. Dexametason-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J Biol Chem. 268:1993;3037-3039.
7. Brodin O., Lennartsson L., Nilsson S. Single-dose and fractionated irradiation of four human lung cancer cell lines in vitro. Acta Oncol. 30:1991;967-974.
8. Brodin O., Arnberg H., Bergh J., Nilsson S. Increased radioresistance of an in vitro transformed human small cell lung cancer cell line. Lung Cancer. 12:1995;183-198.
9. Campos L., Rovalult J.P., Sabido O., Oriol P., Roubi N., Vasselon C., Archimbaud E., Magaud J.P., Guyotat D. High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood. 18:1993;3091-3096.
10. Carmichael J., DeGraff W., Gamson J., Russo D., Gazdar A., Levitt M., Minna J., Mitchell J. Radiation sensitivity of human lung cancer cell lines. Eur J Cancer Clin Oncol. 25:1989;527-534.
11. Carney D.N., Mitchell J.B., Kinsella T.J. In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants. Cancer Res. 43:1983;2806-2811.
12. Carson D.A., Ribeiro J.M. Apoptosis and disease. Lancet. 341:1993;1251-1254.
13. Castro J., Heiden T., Wang N., Tribukait B. Preparation of cell nuclei from fresh tissues for high-quality DNA flow cytometry. Cytometry. 14:1993;793-804.
14. Collins R.J., Harmin B.V., Gobe G.C., Kerr J.F.R. Internucleosomal DNA cleavage should be not be the sole criterion for identifying apoptosis. Int J Radiat Biol. 61:1992;451-453.
15. Compton M.M. A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev. 11:1992;105-119.
16. D'Amico D., Carbone D., Mitsudomi T., Nau M., Fedorko J., Russell E., Johnson B., Buchhagen D., Bodner S., Phelps R., Gazdar A., Minna J.D. High frequency of somatically acquired p53 mutations in small cell lung cancer cell lines and tumors. Oncogene. 7:1992;339-346.
17. Eerola A.K., Tormanen U., Rainio P., Sormunen R., Bloigu R., Vahankangas K., Lehto V.P., Soini Y., Paakko P. Apoptosis in operated small cell lung carcinoma is inversely related to tumour necrosis and p53 immunoreactivity. J Pathol. 181:1997;172-177.
18. Eichholtz-Wirth H., Stoetzer O., Marx K. Reduced expression of the ICE-related protease CPP32 is associated with radiation-induced cisplatin resistance in HeLa cells. Br J Cancer. 76:1997;1322-1327.
19. Fukunaga-Johnson N., Ryan J.J., Wicha M., Nunez G., Glarke M.F. Bcl-2 protects murine erythroleukemia cells from p53 dependent and independent radiation-induced cell death. Carcinogenesis. 16:1995;1761-1767.
20. Hendry J.H., West C.M. Apoptosis and mitotic cell death: their relative contribution to normal-tissue and tumour radiation response. Int J Radiat Biol. 71:1997;709-719.
21. Hermeking H., Eick D. Mediation of c-myc induced apoptosis by p53. Science. 265:1994;2091-2093.
22. Johnson B.E., Battey J.F., Linnoila I., Becker K.L., Makuch R.W., Snider R.H., Carney D.N., Minna J.D. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc. J Clin Invest. 78:1986;525-532.
23. Komaki R., Fujii T., Perkins P., Ro J.Y., Allen P.K., Mason K.A., Mountain C.F., Milas L. Apoptosis and mitosis as prognostic factors in pathologically staged N1 non small cell lung cancer. Int J Radiat Oncol Biol Phys. 36:1996;601-605.
24. Kennedy M.M., Lamb D., King G., Kerr K.M. Cell proliferation, cell loss and expression of bcl-2 and p53 in pulmonary neoplasms. Br J Cancer. 75:1997;545-547.
25. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide range implications in tissues kinetics. Br J Cancer. 26:1972;239-257.
26. Liebermann D.A., Hoffman B., Steinman R.A. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene. 11:1995;199-210.
27. McConkey D.J., Zhivotovsky B., Orrenius S. Apoptosis-molecular mechanisms and biomedical implications. Mol Aspects Med. 17:1996;1-110.
28. McDonell T.J., Beham A., Sarkiss M., Andersen M.M., Lo P. Importance of the Bcl-2 family in cell death regulation. Experientia. 52:1996;1008-1017.
29. Mundle S.D., Gao X.Z., Khan S., Gregory S.A., Preisler H.D., Raza A. Two insitu labeling techniques reveal different patterns of DNA fragmentation during spontaneous apoptosis in vivo and induced apoptosis in vitro. Anticancer Res. 15:1995;1895-1904.
30. Oberhammer F., Wilson J.W., Dive C., Morris I.D., Hickman J.A., Wakeling A.E., Walder P.R., Sikorska M. Apoptotic death in epitelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in absence of internucleosomal fragmentation. EMBO J. 12:1993;679-3684.
31. Pezzella F., Turley H., Kuzu I., Tungekar M.F., Dunill M.S., Pierce CB, Harris A., Gatter K.C., Mason D.Y. Bcl-2 protein in non small-cell lung carcinoma: immunohistochemical evidence of abnormal expression and correlation with survival. N Engl J Med. 329:1993;690-694.
32. Reeve J.G., Xiong J., Morgan J., Bleehen N.M. Expression of apoptosis-regulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistance. Br J Cancer. 73:1996;1193-1200.
33. Ryan K.M., Birnie G.D. Myc oncogenes: the enigmatic family. Biochem J. 314:1996;713-721.
34. Sirzén F., Heiden T., Nilsson A., Bergh J., Skog S., Lewensohn R. Characterisation of the G1/S cell cycle checkpoint defect in three lung carcinoma cell lines with different intrinsic radiosensitivities. Anticancer Res. 17:1997;3381-3386.
35. Sirzén F., Nilsson A., Zhivotovsky B., Bergh J., Lewensohn R. Spontaneous and radiation-induced apoptosis in lung carcinoma cells with different intrinsic radiosensitivities. Anticancer Res. 18:1998;695-700.
36. van Slooten H.-J., van de Vijver M.J., van de Velde C.J.H., van Dierendonck J.H. Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity. Br J Cancer. 77:1998;789-796.
37. Sorenson C.M., Barry M.A., Eastman A. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst. 82:1990;749-755.
38. Tu H., Jacob S.C., Borkowski A., Kyprianou N. Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-beta1 and bcl-2 expression. Int J Cancer. 69:1996;357-363.
39. Wheeler J.S., Stephens L., Eifel P., Ang K., Milas L., Allen P., Meyn R.E. Apoptosis as a predictor of tumor response to radiation in stage 1B cervical adenocarcinoma. Int J Radiat Oncol Biol Phys. 32:1995;1487-1493.
40. Zhivotovsky B., Burgess D.H., Orrenius S. Proteases in apoptosis. Experientia. 52:1996;968-978.
41. Zhivotovsky B., Wade D., Gahn A., Orrenius S., Nicotera P. Formation of 50 kbp chromatin fragments in isolated liver nuclei is mediated by protease and endonuclease activation. FEBS Lett. 351:1994;150-154.
42. Ziegler A., Luedke G.H., Fabbro D., Altmann K.H., Stahel R.A., Zangmeister-Wittke U. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence. J Natl Cancer Inst. 89:1997;1027-1036.